Investorideas.com  big ideas for global investors Search www.investorideas.com
   Member Access       Sign-up       Newsfeeds        Companies        Stock Directories       Research       Video       Funding   




Infinite Group, Inc. (IMCI) Partners with ThirtySix Software, Appoints New VP of Sales to Head Growth Initiatives

Ideas get bigger when you share them...

July 1, 2014 (www.investorideas.com newswire) Infinite Group, a growing Rochester, New York-based IT services firm, has been signed as an exclusive channel partner of ThirtySix Software, creator of the SmartDocs innovative software product. IGI also names Laila Benarab as vice president of sales for its Content Management Practice, which focuses on all business segments including government, small-to-medium business, and enterprise.

Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner

ThirtySix Software’s lead product is SmartDocs, a Microsoft® Word®-based content management and content reuse solution that helps writers streamline content creation and maintenance across Microsoft Word documents. The solution offers a range of features that make reusable content easier to share, review, update, approve, track, and manage, with highlights such as configurable metadata, content approval, conditional text, and bulk updates to further enhance the productivity of content authors and eliminate repetitive costs.

Benarab will be responsible with leading the development of IGI’s service solution suite, which includes products made by ThirtySix Software. She has also been tasked with increasing IGI’s customer base in content management services, developing relationships with current and new technology partners, and bringing the latest best practices to IGI’s clients.

"Content Management is a growing tech segment and our clients are asking for support in this vital area," Jim Villa, IGI’s CEO, stated in the news release. "Our new relationship with ThirtySix Software and their flagship product, SmartDocs, allows us to provide our customers with the leading tools available in the marketplace today. With Laila’s guidance, we expect our business to grow substantially."

With more than 15 years of high-tech business-to-business sales experience, Benarab’s resume includes employment with a wide range of recognizable companies and government agencies including Motorola, Oracle, and Computer Sciences Corp. (CSC), where she worked on an IT federal government contract supporting the Environmental Protection Agency (EPA).

For more information, visit www.igius.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for "The QualityStocks Daily Newsletter" at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks "Ones to Watch" http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

VistaGen Therapeutics, Inc. (VSTA) Drug Rescue Model Resuscitates Failed Drug Candidates

VistaGen Therapeutics is focused on drug rescue and regenerative medicine, applying its pluripotent stem cell technology toward the discovery of small molecule drugs and biologics that trigger the endogenous growth and healing processes that enable the human body to repair tissue damage caused by certain degenerative diseases.

For more than 15 years, VistaGen’s research and development teams and collaborators have developed proprietary methods for controlling the differentiation of pluripotent stem cells with a particular focus on human heart and liver cells for the company’s drug rescue programs.

Drug rescue refers to the process of taking small molecule drug candidates that were previously discovered and validated by pharmaceutical companies but were terminated in the development stages due to unexpected heart or liver safety concerns. The playing field here is tremendous – roughly one-third of all potential new drug candidates fail in preclinical or clinical development due to these toxicity concerns, resulting in the loss of millions of dollars in investments and countless hours of research.

For a better idea of how dire these facts are, consider that last year the U.S. pharmaceutical industry pumped more than $51 billion into research and development. Sounds promising, but the FDA’s Center for Drug Evaluation and Research (CDER) only approved 27 novel drugs (NMEs) in 2013. In fact, since 2003, CDER has approved an average of 27 NMEs per year, and on is track to continue the average with 17 approved NMEs thus far in 2014.

Using its proprietary stem cell technology, VistaGen aims to build a diverse drug pipeline of small molecule variants (Drug Rescue Variants), picking up where the pharmaceutical companies left off. Applying its CardioSafe 3D™ and, when validated, LiverSafe 3D™, biological assay systems, VistaGen is in a unique position to produce new Drug Rescue Variants faster and less expensively than entities using conventional animal and in vitro cell culture testing.

These bioassay systems will be used to identify and validate that the Drug Rescue Variant demonstrates an improved efficacy with reduced toxicity compared to the original drug candidate. From here, the company plans to license its lead Drug Rescue Variant, benefiting from economic participation rights, development milestone payments and royalties on commercial sales.

For more information visit www.vistagen.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for "The QualityStocks Daily Newsletter" at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks "Ones to Watch" http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Big Tree Group, Inc. (BIGG) Expands Toy Distribution Business in Latin America

Big Tree Group is reaching new heights with its toy exporting business. After experiencing record growth last year, growth propelled by Shantou Big Tree Toys, the wholly-owned subsidiary which operates Big Tree’s toy exporting business, the company is anticipating continued sales growth in 2014 and, so far, that expectation is being met.

The company targeted export sales as a key area for future growth and has dedicated significant resources toward establishing the Big Tree Toys brand as a dependable source for quality toys. The company’s estimation is that the toy exporting business at Shantou Big Tree Toys accounted for approximately $15 million of total revenues in 2013, an increase of approximately 50% for that fiscal year. Such solid sales growth substantiates the success of the focus on export sales.

The robust revenue growth in 2013 and emphasis on tested quality and value pricing have also allowed the company to grow its international customer base, and it is seeing intensifying demand from toy markets around the world: North America, South America, the Mideast, Asia and Europe.

Big Tree Group is making waves in South America in particular. In June 2014, the company announced that it received purchase orders with an estimated value of $400,000 from the operator of a chain of retail stores in Costa Rica, stores that supply home goods, family products, and hardware to consumers. The purchase orders are for toy products, including play sets, dolls, electronic learning games and instruments. Big Tree Group views these orders as further proof that the company is moving in the right direction with its assertive value pricing and global market expansion efforts. The company expects to conclude the delivery of the toys early in the third quarter of 2014 and sees considerable opportunity to expand its relationship with this customer in the future.

Big Tree Group has built a strong foundation for growth through its emphasis on custom service and quality control systems and sourcing capabilities developed over the years. Laser focus on these areas has enhanced the company’s standing as a reliable "one stop shop" for commercial toy buyers across the globe. Management’s goal now is to continue building on the company’s reputation and position so it can prolong its strong financial performance for years to come.

For more information, visit www.bigtreegroup.net

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for "The QualityStocks Daily Newsletter" at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks "Ones to Watch" http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

More Info:

This news is published on the Investorideas.com Newswire and its syndicated partner network

Publish Your News - Send a release
News now!

Get free news alerts: Sign up here

Published at the Investorideas.com Newswire - Big ideas for Global Investors

Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news as well as creates original content as a news source. Original content created by investor ideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and global syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions and advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers.

More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Disclosure: Investorideas is long shares of OEDV.

BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.



Free News Alerts
Email:  





TOP

Investor Ideas © 2000 - 2014 InvestorIdeas.com®, ECON

Sign up here

login | logout | about us | contact | disclaimer / disclosure |
advertise | company profile directory | partners / links |
job search | privacy policy | trade | services | sitemap |